Home > Insider Trading > Filing (0001209191-20-033310)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1697532	Applied Therapeutics Inc.	APLT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1775490	Shoshana Shendelman	C/O Applied Therapeutics, Inc. 545 Fifth Avenue, Suite 1400 New York NY 10017	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-02-28	290,280	$0.00	3,014,005	No	5	G	Direct
Common Stock	Disposition	2020-02-28	709,720	$0.00	2,304,285	No	5	G	Direct
Common Stock	Acquisiton	2020-02-28	290,280	$0.00	290,280	No	5	G	Indirect	See footnote
Common Stock	Acquisiton	2020-02-28	709,720	$0.00	709,720	No	5	G	Indirect	See footnote
Common Stock	Acquisiton	2020-05-28	27,624	$1.00	581,909	No	4	M	Direct
Common Stock	Acquisiton	2020-05-28	97,376	$1.44	679,285	No	4	M	Direct
Common Stock	Disposition	2020-05-28	125,000	$42.70	554,285	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	5	G	Direct
No	5	G	Indirect	See footnote
No	5	G	Indirect	See footnote
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-28	27,624	$0.00	27,624	$1.00
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-28	97,376	$0.00	97,376	$1.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2027-03-27	No	4	M	Direct
629,605		2028-03-07	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,750,000	Indirect	See footnote
Common Stock	88,397	Indirect	See footnote
Common Stock	1,492,094	Indirect	See footnote

Footnotes

These transactions do not reflect sales, but reflect gifts made for estate-planning purposes from the reporting person to her spouse and/or associated trust.
Through a family trust controlled by the reporting person.
Through reporting person's spouse.
Through a grantor retained annuity trust.
These transactions reflect the exercise of previously vested stock options.
On May 28, 2020, the reporting person exercised options to purchase 125,000 shares of common stock and sold such shares in a block trade negotiated at a discount from the market closing price of $46.92 per share, for a gross sales price of $42.70.
Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.
Through a family trust controlled by the reporting person's spouse.
These options became fully vested on April 22, 2019.
These options became fully vested on March 7, 2020.